Terry Douglass

Back to Dougherty Award Winners
Douglass

Terry Douglass

CEO, ProNova Solutions, LLC
Chairman, Provision Center for Proton Thearpy
President, ProVision Healthcare, LLC
President, Provision Trust, Inc.
Founder, ProVision Foundation

Education

  • B.S. 1965 Electrical Engineering, the University of Tennessee, Knoxville
  • M.S. 1966 Electrical Engineering, the University of Tennessee, Knoxville
  • Ph.D. 1967 Electrical Engineering, the University of Tennessee, Knoxville

Terry Douglass received all 3 degrees in electrical engineering from UT. One of the four cofounders of CTI Molecular Imaging, Inc., Douglass served as Chairman of the Board starting in 1983 for the public company that specialized in the development, production and distribution of products and services for the medical diagnostic imaging market. Douglass held this position until 2005 when CTI was acquired by Siemens. Douglass also served as president and CEO of CTI from its formation in 1983 until 2003.

During his years at CTI, Douglass played an integral role in the development and commercialization of positron emission tomography (PET) technology, and was instrumental in the development of Medicare reimbursement for PET services.

Moving to ProVision, Douglass helped spearhead the company’s primary initiative in healthcare is the development of a world-class cancer care capability, named Provision Health Alliance at Dowell Springs, that will include proton therapy capability and most all other diagnostic and treatment modalities for cancer care. There are only 9 proton therapy centers across the country.

Douglass founded ProNova in 2005. ProNova develops optimal solutions for the needs of the proton market through collaboration with established proton suppliers and providers. Connected to Provision Health Alliance and the Provision Center for Proton Therapy, ProNova is the only “Total Solution” provider in proton therapy. Douglass is the CEO and Chairman of the Board of Directors for ProNova, and is spearheading the company’s success.

Douglass is very active in the community and has shared his expertise in Proton Therapy across a variety of boards including: Provision Foundation, LLC, Provision Healthcare, LLC, East Tennessee Diagnostic Center, LLC, Provision Imaging, LLC, Provision Health Partners, LLC, Provision Properties, LLC, Provision Trust, Inc., Provision Radiation Therapy, LLC, CTI Molecular Imaging, Inc., Cyclotron Systems Inc., PETNet Pharmaceutical Services, Inc., Computational Systems, Inc.

Douglass is also active in some well-known local businesses including: YMCA, Knoxville Chamber of Commerce, Hope Resource Center, Young Life, the UT Medical Center, CTI Biomedical Research Center, UT Chancellor’s Associates, and the UT Tickle College of Engineering Board of Advisors.

Douglass said he was “honored and humbled” to receive the Dougherty Award, and added that he was “blessed by and thankful for all the many contributions made by the university and its staff to his education and career.”